Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc.
MLYS
Valuace
70
Růst
45
Zdraví
75
Cena
$ 42.88
Dnes
+1.36 (4.33%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.8B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-30%
ROA
-29%
PE
-11
PS
0
Cena 1R
8-48
⌀ Cena
26.04
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda

Profil

Mineralys Therapeutics, Inc., biofarmaceutická společnost v klinickém stadiu, která vyvíjí terapie pro léčbu hypertenze a souvisejících kardiovaskulárních onemocnění. Klinicky hodnoceným lékovým kandidátem je lorundrostat, patentovaný, perorálně podávaný, vysoce selektivní inhibitor aldosteronové syntázy k léčbě pacientů s nekontrolovanou nebo rezistentní hypertenzí. Společnost byla založena v roce 2019 a sídlí v Radnoru v Pensylvánii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
51
Založení
2023-02-10
Adresa
150 N. Radnor Chester Rd.
CEO
Jon Congleton

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020
Total Revenues0.000.000.000.000.000.000.00
Cost of Revenues28.0059.000.000.000.000.000.00
Gross Profit-28.00-59.000.000.000.000.000.00
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.000.000.000.000.000.000.000.000.00
Cost of Revenues13.0015.000.000.000.000.000.008.000.000.00
Gross Profit-13.00-15.000.000.000.000.000.00-8.000.000.00
Operating Income TTM 202520242023202220212020
R&D Expenses0.000.000.0070,361.0026,250.0016,308.002,411.00
Selling General & Admin Expenses0.000.000.0014,296.005,229.002,417.00532.00
Depreciation & Amortization59.0059.0043.000.000.001.00-1.00
Total Operating Expenses170,576.00170,604.00192,403.0084,657.0031,479.0018,725.002,943.00
Operating Income-170,604.00-170,604.00-192,403.00-84,657.00-31,479.00-18,725.00-2,943.00
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.0023,685.0022,499.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.004,026.003,774.00
Depreciation & Amortization13.0015.0016.0015.0015.0011.009.008.0043.81-39.59
Total Operating Expenses38,267.0041,116.0046,746.0044,447.0051,767.0060,106.0045,168.0035,354.0027,711.0026,273.00
Operating Income-38,280.00-41,131.00-46,746.00-44,447.00-51,767.00-60,106.00-45,168.00-35,362.00-27,711.00-26,273.00
Net Income TTM 202520242023202220212020
Interest Income15,953.0015,953.0014,588.0012,756.001,676.000.000.00
Interest Expense0.000.000.000.000.0027.00115.00
Other Expense15,953.0015,953.0014,593.0012,759.004.00-656.00-368.00
IBT-154,651.00-154,651.00-177,810.00-71,898.00-29,799.00-19,408.00-3,426.00
Income Tax Expense0.000.000.000.000.0027.00115.00
Net Income-154,651.00-154,651.00-177,810.00-71,898.00-29,799.00-19,408.00-3,426.00
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income6,045.004,195.003,474.002,239.002,809.003,774.004,152.003,853.003,321.003,513.00
Interest Expense0.000.000.000.000.000.000.000.000.000.00
Other Expense6,046.004,199.003,472.002,236.002,821.003,764.004,154.003,854.003,322.003,513.00
IBT-32,234.00-36,932.00-43,274.00-42,211.00-48,946.00-56,342.00-41,014.00-31,508.00-24,389.00-22,760.00
Income Tax Expense0.000.000.000.000.000.000.000.00-43.8139.59
Net Income-32,234.00-36,932.00-43,274.00-42,211.00-48,946.00-56,342.00-41,014.00-31,508.00-24,389.00-22,760.00
Per Share Data TTM 202520242023202220212020
EPS$0.00$0.00$0.00$-1.99$-0.76$-1.04$-0.35
EPS Diluted$0.00$0.00$0.00$-1.99$-0.76$-1.04$-0.35
Shares Outstanding80,545.7467,656.3648,539.0036,188.0039,056.6518,644.009,909.80
Diluted Shares Outstanding80,545.7467,656.3648,539.8036,188.2539,056.6518,644.009,909.80
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.61$-0.55
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.61$-0.55
Shares Outstanding80,545.7470,594.5065,451.3053,163.0049,957.0049,815.0049,356.0044,900.0040,093.2441,105.12
Diluted Shares Outstanding80,545.7470,594.5065,451.3053,163.5549,957.9149,815.1949,356.2944,900.7640,093.2441,105.12
Current Assets TTM 20242023202220212020
Cash And Equivalents67,856.00114,091.0049,304.0087,701.0010,612.001,409.00
Short Term Investments243,259.0084,096.00187,263.0022,409.000.000.00
Total Cash & ST Investments311,115.00198,187.00236,567.00110,110.0010,612.001,409.00
Accounts Receivable0.000.000.000.000.000.00
Inventory0.000.000.000.000.000.00
Other Current Assets6,886.007,164.0012,536.002,701.00510.0057.00
Total Current Assets318,001.00205,351.00249,103.00110,110.0011,122.001,466.00
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents217,597.00101,788.00165,007.00114,091.0097,274.0067,856.0090,418.0049,304.00265,890.00101,140.00
Short Term Investments0.00223,128.00178,019.0084,096.00166,329.00243,259.00248,147.00187,263.00167,461.00159,957.00
Total Cash & ST Investments217,597.00324,916.00343,026.00198,187.00263,603.00311,115.00338,565.00236,567.00265,890.00261,097.00
Accounts Receivable0.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.00
Other Current Assets382,199.0010,353.0011,480.007,164.004,129.006,886.008,254.0012,536.0023,228.008,391.00
Total Current Assets599,796.00335,269.00354,506.00205,351.00267,732.00318,001.00346,819.00249,103.00265,375.00269,488.00
Long-Term Assets TTM 20242023202220212020
Net Property, Plant & Equipment42.0053.000.000.000.000.00
Goodwill0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Long-Term Investments0.000.002,482.000.000.000.00
Other Long-Term Assets449.00499.0051.000.000.000.00
Total Long-Term Assets491.00552.002,533.004,332.003.0020.00
Total Assets318,492.00205,903.00251,636.00114,442.0011,125.001,486.00
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment7.0022.0038.0053.0069.0042.0051.000.000.000.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.000.000.000.000.00
Long-Term Investments0.000.000.000.000.000.000.002,482.0012,129.0021,678.00
Other Long-Term Assets144.00433.00397.00499.00452.00449.00379.0051.0051.0051.00
Total Long-Term Assets151.00455.00435.00552.00521.00491.00430.002,533.0012,180.0021,729.00
Total Assets599,947.00335,724.00354,941.00205,903.00268,253.00318,492.00347,249.00251,636.00277,555.00291,217.00
Current Liabilities TTM 20242023202220212020
Accounts Payable1,707.00479.00601.001,907.00763.00529.00
Short-Term Debt0.000.000.000.000.004,500.00
Other Current Liabilities26,690.0014,167.009,881.006,160.004,291.0054.00
Current Liabilities28,397.0014,646.0010,482.008,067.005,054.005,083.00
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable1,121.003,164.00373.00479.003,106.001,707.004,261.00601.005,573.002,196.00
Short-Term Debt0.000.000.000.000.000.000.000.000.000.00
Other Current Liabilities22,399.0019,009.0013,013.0014,167.0028,215.0026,690.0014,943.009,881.007,970.004,011.00
Current Liabilities23,520.0022,173.0013,386.0014,646.0031,321.0028,397.0019,204.0010,482.0013,543.006,207.00
Long-Term Liabilities TTM 20242023202220212020
Long-Term Debt0.000.000.000.000.000.00
Capital Leases0.000.000.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.00
Total Liabilities28,397.0014,646.0010,482.00166,711.0034,050.005,083.00
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.000.000.000.000.000.000.000.000.000.00
Capital Leases0.000.000.000.000.000.000.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities23,520.0022,173.0013,386.0014,646.0031,321.0028,397.0019,204.0010,482.0013,543.006,207.00
Total Common Equity TTM 20242023202220212020
Common Stock5.005.004.001.001.001.00
Retained Earnings-197,230.00-302,518.00-124,708.00-52,810.00-23,011.00-3,603.00
Comprehensive Income0.000.000.000.000.000.00
Total Common Equity290,095.00191,257.00241,154.00-52,269.00-22,925.00-3,597.00
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock8.006.006.005.005.005.005.004.004.004.00
Retained Earnings-424,935.00-388,003.00-344,729.00-302,518.00-253,572.00-197,230.00-156,216.00-124,708.00-100,319.00-77,559.00
Comprehensive Income0.000.000.000.000.000.000.00-251,636.00-277,555.000.00
Total Common Equity576,427.00313,551.00341,555.00191,257.00236,932.00290,095.00328,045.00241,154.00264,012.00285,010.00
Other TTM 20242023202220212020
Total Debt0.000.000.000.000.004,500.00
Book Value290,095.00191,257.00241,154.00-52,269.00-22,925.00-3,597.00
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value576,427.00313,551.00341,555.00191,257.00236,932.00290,095.00328,045.00241,154.00264,012.00285,010.00
Cash Flow From Operating Activities TTM 202520242023202220212020
Net Income-119,671.00-154,651.00-177,810.00-71,898.00-29,799.00-19,408.00-3,426.00
Depreciation & Amortization17.0059.0043.000.000.000.000.00
Stock-Based Compensation8,098.0019,324.0011,336.005,060.00455.0080.001.00
Change Working Capital23,643.002,731.009,522.00-7,470.00772.004,085.00480.00
Change In Accounts Receivable0.00-166.00424.000.000.000.000.00
Change In Accounts Payable8,904.000.000.000.000.000.000.00
Change In Inventories0.000.000.000.000.000.000.00
Other Non-cash Items-4,287.00-9,879.00-9,405.00-6,865.00-649.00684.00482.00
Cash from Operations-97,297.000.000.00-81,173.00-29,221.00-14,559.00-2,463.00
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-32,234.00-36,932.00-43,274.00-42,211.00-48,946.00-56,342.00-41,014.00-31,508.00-24,389.00-22,760.00
Depreciation & Amortization13.0015.0016.0015.0015.0011.009.008.000.000.00
Stock-Based Compensation5,285.005,841.004,553.003,645.003,134.003,139.002.872,191.001,457.001,578.00
Change Working Capital-6,744.004,600.0010,765.00-5,890.00-19,709.005,718.0010,834.0012,679.00-3,983.004,113.00
Change In Accounts Receivable-181.0010.00-47.000.0098.0023.00184.000.000.000.00
Change In Accounts Payable0.000.000.00-1,546.000.000.000.000.00503.000.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-4,208.00-2,396.00-2,229.00-1,046.00-1,337.00-2,712.0022.13-2,509.00-2,066.00-1,962.00
Cash from Operations0.000.000.000.000.000.000.000.00-28,981.00-19,031.00
Cash Flow From Investing Activities TTM 202520242023202220212020
Capital Expenditure-59.00-15.00-96.000.000.000.000.00
Acquisitions0.000.000.000.000.000.000.00
Investments-379,739.00-814,738.00-373,445.00-347,972.00-71,759.000.000.00
Sales of Investment327,500.00425,000.00488,500.00187,500.0050,000.000.000.00
Other Investing Activities-59.980.000.000.000.000.000.00
Cash from Investing-52,298.000.000.00-160,472.00-21,759.000.000.00
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-15.000.000.000.000.00-37.000.00-59.000.000.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments-268,474.00-300,507.00-117,881.00-127,876.00-63,930.00-58,858.00-127,264.00-123,393.00-73,089.00-55,993.00
Sales of Investment165,000.00150,000.0075,000.0035,000.00147,500.00138,500.00135,000.0067,500.0065,000.0060,000.00
Other Investing Activities0.000.000.000.000.000.000.000.00-8.094.01
Cash from Investing0.000.000.000.000.000.000.000.00-8,089.004,007.00
Cash Flow From Financing Activities TTM 202520242023202220212020
Debt Repaid0.000.000.000.000.000.000.00
Debt Issued0.000.000.000.000.00-4,500.004,500.00
Issuance of Common Stock116,311.000.000.00202,990.000.000.000.00
Repurchase of Common Stock64.580.000.000.000.000.00-20.00
Dividends Paid0.000.000.000.000.000.000.00
Other Financing Activities-346.740.000.00258.00128,019.000.003,850.00
Cash from Financing116,311.000.000.00203,248.00128,019.0023,812.003,830.00
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued0.000.000.000.000.000.000.000.000.000.00
Issuance of Common Stock0.000.000.000.000.000.000.000.0074.00184.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.0064.580.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.0074.00184.00
Cash from Financing0.000.000.000.000.000.000.000.0074.00184.00
Cash position TTM 202520242023202220212020
Net Change in Cash-33,284.0058,830.0064,787.00-38,397.0077,039.009,253.001,367.00
Closing Cash Balance67,856.00172,921.00114,091.0049,304.0087,701.0010,662.001,409.00
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-44,676.00115,809.00-63,219.0050,916.0016,817.0029,418.00-22,562.0041,114.00-36,996.00-14,840.00
Closing Cash Balance172,921.00217,597.00101,788.00165,007.00114,091.0097,274.0067,856.0090,418.0049,304.0086,300.00
Free Cash Flow TTM 202520242023202220212020
Free Cash Flow-97,356.00-142,431.00-166,410.00-81,173.00-29,221.00-14,559.00-2,463.00
Real Free Cash Flow-105,454.00-161,755.00-177,746.00-86,233.00-29,676.00-14,639.00-2,464.00
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-37,903.00-28,872.00-30,169.00-45,487.00-66,843.00-50,223.00-30,146.00-19,198.00-28,981.00-19,031.00
Real Free Cash Flow-43,188.00-34,713.00-34,722.00-49,132.00-69,977.00-53,362.00-30,148.87-21,389.00-30,438.00-20,609.00
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-11.5-8.6-1.4
P/S05615.39.4
P/B3.42.15.2
P/FCF-10.4-8.1-1.5
Market cap$2.8$1.8
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %0 %0 %
Debt to Income0 %0 %0 %
Debt to Free cash flow0 %0 %0 %
Interest expense percentage0 %0 %44.7 %
Current ratio25.5 16.5 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-26.8 %-18.6 %0 %
ROA-25.8 %-33.3 %0 %
CapEx to Revenue0 %6.8 %0 %
RaD to Revenue0 %32116 %0 %
ROEM0.0 0

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin0 %-1.7 %68.7 %
Operating margin0 %-37328.3 %35.5 %
Net margin0 %-35068.6 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding70.6 mil 37.8 mil
Employee count0.1 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader